Utrecht University granted Albertus Dominicus Marcellinus Erasmus Osterhaus his first degree in veterinary medicine in 1974, beginning a career focused on the intersection of animal and human pathology. Born in Amsterdam in 1948, the physician and virologist later established himself as an authority on pandemic influenza, avian viruses, and the identification of previously unrecognized viral pathogens.
Academic and Research Career
After graduating cum laude, Osterhaus completed a dissertation on feline infectious peritonitis in 1978. He spent sixteen years at the National Institute for Public Health and the Environment in Bilthoven, concluding his tenure as head of the laboratory for Immunobiology. His academic trajectory included appointments at Utrecht University and a professorship at Erasmus University Medical Centre Rotterdam starting in 1993. He eventually transitioned into the role of head of the Department of Viroscience before moving to the University of Veterinary Medicine Hannover in Germany to focus on zoonotic research. Beyond his university obligations, he maintains a position at Artemis BV in Utrecht.
Twenty questions, eight minutes on the clock, and a percentile measured against everyone who has taken it. No sign-up.
Take the IQ test →Viral Pathogens and Public Health
Osterhaus gained recognition for his contributions to the identification of the SARS coronavirus. His research team discovered in 2004 that pegylated interferon alpha could be utilized to combat the virus. Throughout his career, he has supervised over 40 doctoral students and authored more than 1,000 scientific papers in publications such as Science, Nature, and The Lancet. He served on various international scientific committees and has provided expertise to the Dutch Health Council and the European Scientific Working group on Influenza.
Recognition and Public Scrutiny
The scientific community acknowledged his work through numerous honors, including the M. W. Beijerinck Prize for Virology in 1998 and the Scientific Grand Prize of the NRJ Fondation in 2007. In 2003, he was appointed a Commander of the Order of the Netherlands Lion, and he became a member of the German Academy of Sciences Leopoldina in 2016. However, his career also faced public controversy. During the 2009 H1N1 pandemic, critics accused him of exaggerating health risks to influence government policy, which resulted in significant vaccine purchases. Furthermore, questions were raised regarding his 9.8% share in ViroClinics B.V. during his time as a government consultant, though he denied personal financial gain from those policy decisions.
Fast facts
- Born: 1948, Amsterdam
- Education: Utrecht University
- Notable Award: M. W. Beijerinck Prize for Virology (1998)
- Knighthood: Commander of the Order of the Netherlands Lion (2003)
- Former Employer: National Institute for Public Health and the Environment
- Academic Membership: German Academy of Sciences Leopoldina
- Research focus: Avian influenza, measles, and influenza A
Questions readers ask
What is the primary focus of Osterhaus’s research?
He specializes in virology, specifically focusing on influenza, zoonotic diseases, and the identification of new viral pathogens.
Did Osterhaus hold government advisory roles?
Yes, he served as a government consultant, notably providing advice regarding influenza pandemic measures.
Achievements
- M. W. Beijerinck Prize for Virology — 1998
- Commander of the Order of the Netherlands Lion
- Scientific Grand Prize of the NRJ Fondation — 2007
- Held posts at Utrecht University and Erasmus University Rotterdam
- Fields: Netherlands, antibody and measles
